In this consecutive case series (n = 149) from the Breast Cancer Risk and Lifestyle (BCRL) study, plasma levels of pro‐angiogenic factors, including VEGF‐C, ANGs, and Tie‐2, were assessed using ELISA. This evidence concerns the gene VEGFC and breast cancer.